Traders Purchase Large Volume of Quantum-Si Call Options (NASDAQ:QSI)

Quantum-Si Incorporated (NASDAQ:QSI) was the target of some unusual options trading activity on Thursday. Stock investors bought 20,554 call options on the company. This represents an increase of 1,021% compared to the average daily volume of 1,834 call options.

Institutional Trading of Quantum-Si

Several institutional investors have recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its holdings in Quantum-Si by 15.6% in the second quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock valued at $131,000 after acquiring an additional 9,005 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in Quantum-Si by 27.4% in the second quarter. The Manufacturers Life Insurance Company now owns 49,082 shares of the company’s stock valued at $96,000 after purchasing an additional 10,564 shares during the period. Prudential Financial Inc. purchased a new stake in Quantum-Si in the second quarter valued at $25,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Quantum-Si by 23.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company’s stock valued at $85,000 after purchasing an additional 13,546 shares during the last quarter. Finally, Cerity Partners LLC purchased a new position in shares of Quantum-Si during the 2nd quarter worth $29,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Quantum-Si Stock Performance

Shares of QSI stock traded down $0.05 on Friday, hitting $0.74. 6,977,771 shares of the stock traded hands, compared to its average volume of 2,580,721. The firm’s 50-day moving average price is $0.86 and its two-hundred day moving average price is $0.93. The stock has a market capitalization of $161.10 million, a PE ratio of -1.61 and a beta of 3.24. Quantum-Si has a twelve month low of $0.69 and a twelve month high of $3.10.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11). The firm had revenue of $0.34 million during the quarter, compared to analysts’ expectations of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 45.05%. On average, equities research analysts anticipate that Quantum-Si will post -0.49 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research report on Friday. Weiss Ratings downgraded shares of Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $1.00.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.